140 related articles for article (PubMed ID: 20499474)
41. [HPV immunization for the prevention of cervical cancer].
Mougin C; Bourgault-Villada I; Coursaget P
Presse Med; 2009 Dec; 38(12):1750-68. PubMed ID: 19765945
[TBL] [Abstract][Full Text] [Related]
42. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
Schiffman M
Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850
[TBL] [Abstract][Full Text] [Related]
43. The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
Yang A; Farmer E; Lin J; Wu TC; Hung CF
Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207
[TBL] [Abstract][Full Text] [Related]
44. HPV vaccine protects at multiple sites, even for some previously exposed.
Printz C
Cancer; 2015 Sep; 121(17):2863. PubMed ID: 26291437
[No Abstract] [Full Text] [Related]
45. Genital HPV types in Australia.
Brotherton J; Garland S; Donovan B
Lancet Infect Dis; 2012 Feb; 12(2):102-3. PubMed ID: 22281139
[No Abstract] [Full Text] [Related]
46. Human papillomavirus infection: the role of vaccination in pediatric patients.
Nichols JR; Stovall SH; Jacobs RF
Clin Pharmacol Ther; 2007 Apr; 81(4):607-10. PubMed ID: 17314926
[TBL] [Abstract][Full Text] [Related]
47. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
Gunasekaran B; Jayasinghe Y; Brotherton JM; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
Vaccine; 2015 Feb; 33(6):826-31. PubMed ID: 25444782
[TBL] [Abstract][Full Text] [Related]
48. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
Poljak M
Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
[No Abstract] [Full Text] [Related]
49. Human papillomavirus vaccines: who should get them and why?
Paulus S; Dobson S
Adv Exp Med Biol; 2008; 609():145-53. PubMed ID: 18193663
[No Abstract] [Full Text] [Related]
50. Unresolved questions concerning human papillomavirus infection and transmission: a modelling perspective.
Regan DG; Philp DJ; Waters EK
Sex Health; 2010 Sep; 7(3):368-75. PubMed ID: 20719229
[TBL] [Abstract][Full Text] [Related]
51. [Vaccination against HPV in adults].
Gil Á
Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():22-5. PubMed ID: 20084345
[No Abstract] [Full Text] [Related]
52. Recent progress in vaccination against human papillomavirus-mediated cervical cancer.
McKee SJ; Bergot AS; Leggatt GR
Rev Med Virol; 2015 Mar; 25 Suppl 1():54-71. PubMed ID: 25752816
[TBL] [Abstract][Full Text] [Related]
53. HPV vaccination in Hong Kong: implications for medical education.
Chan ZC; Chan TS; Lam YM; Lau LM; Li KK; Tam WH
Asian Pac J Cancer Prev; 2011; 12(4):1095-9. PubMed ID: 21790258
[TBL] [Abstract][Full Text] [Related]
54. Issues in human papillomavirus vaccination in adolescents.
Moscicki AB; Smith JS
J Adolesc Health; 2008 Oct; 43(4 Suppl):S1-4. PubMed ID: 18809142
[No Abstract] [Full Text] [Related]
55. Design of a large outcome trial for a multivalent human papillomavirus L1 virus-like particle vaccine.
Luxembourg A; Bautista O; Moeller E; Ritter M; Chen J
Contemp Clin Trials; 2015 May; 42():18-25. PubMed ID: 25749310
[TBL] [Abstract][Full Text] [Related]
56. Human papillomavirus: current status and issues of vaccination.
Malik H; Khan FH; Ahsan H
Arch Virol; 2014 Feb; 159(2):199-205. PubMed ID: 24022639
[TBL] [Abstract][Full Text] [Related]
57. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
[No Abstract] [Full Text] [Related]
58. [Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination].
Six L; Joura EA
Wien Med Wochenschr; 2007; 157(5-6):130-2. PubMed ID: 17427010
[No Abstract] [Full Text] [Related]
59. Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.
Kines RC; Zarnitsyn V; Johnson TR; Pang YY; Corbett KS; Nicewonger JD; Gangopadhyay A; Chen M; Liu J; Prausnitz MR; Schiller JT; Graham BS
PLoS One; 2015; 10(3):e0120797. PubMed ID: 25785935
[TBL] [Abstract][Full Text] [Related]
60. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
